DERM

Journey Medical Corporation - Common Stock (DERM)

About Journey Medical Corporation - Common Stock (DERM)

Journey Medical Corporation is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$9.56
52 Week Low
$4.31
Market cap
206.3M
Dividend yield
-
Volume
405
Avg. volume
134,465
P/E ratio
-31.55

Journey Medical Corporation - Common Stock News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$9.56
52 Week Low
$4.31
Market cap
206.3M
Dividend yield
-
Volume
405
Avg. volume
134,465
P/E ratio
-31.55